ELITECON vs INDOUS: Stock Comparison
ELITECON INTERNATIONAL L is the larger company by market capitalisation. ELITECON INTERNATIONAL L shows a higher ROE, a higher dividend yield and faster revenue growth, while INDO US BIOTECH shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ELITECON leads 7; INDOUS leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ELITECON | INDOUS |
|---|---|---|
| Sector | — | Fast Moving Consumer Goods |
| Industry | — | Other Agricultural Products |
Price
| Metric | ELITECON | INDOUS |
|---|---|---|
| Live Price | ₹8.58 | ₹78.29 |
| Day Change | 4.89% | 0.06% |
| Volume | 92.72 L | 2,095 |
| 52-Week High | ₹46.4 | ₹159 |
| 52-Week Low | ₹7.08 | ₹70 |
| Distance from 52W High | -81.51% | -50.76% |
Valuation
| Metric | ELITECON | INDOUS |
|---|---|---|
| Market Cap | ₹1,372 Cr | ₹160 Cr |
| P/E Ratio | 3.7x | 0x |
| P/B Ratio | 2.35x | 0x |
| EPS | ₹0.06 | ₹1.51 |
| Book Value | ₹1 | ₹46.15 |
| Dividend Yield | 0.61% | 0% |
Growth
| Metric | ELITECON | INDOUS |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | -22% |
| EPS Growth (TTM YoY) | 0% | -47.3% |
| Qtr Sales Growth | -71.13% | 26.75% |
| Qtr Profit Growth | -90.79% | 54.05% |
Profitability & Leverage
| Metric | ELITECON | INDOUS |
|---|---|---|
| ROE | 51.34% | 14.18% |
| ROCE | 38.29% | 12.34% |
| Net Margin | 12.69% | 11.88% |
| Operating Margin | 5.26% | 14.64% |
| Debt to Equity | 0x | 0.4x |
Shareholding
As of Dec 2025 • change vs previous quarter| Metric | ELITECON | INDOUS |
|---|---|---|
| Promoter Holding | 59.43% | 68.29% |
| FII Holding | 38%▼ 0.21 pp | 0.01%▼ 0.17 pp |
| DII Holding | 0% | — |
| Public Holding | 2.57%▲ 0.21 pp | 31.7%▲ 0.17 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ELITECON INTERNATIONAL L and INDO US BIOTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.